Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 3, 2010

View Archived Issues

Abiomed hopes to tap into STEMI market with study

Report from Europe: St. Jude receives CE mark, TGA approval for Penta lead

Washington roundup: CMS proposes trial coverage of MRI with ICDs, pacemakers

Deals roundup: Hanger Ortho completes ACP buy for nearly $155M

MDD's food for med-tech thought

Med-Tech Notes

Financings roundup: Sequenom seeks $84M via offering of 14M shares

RSNA notebook: Panel addresses safety in medical imaging use

People in the News

Product Briefs

Medtronic Spine's Horizon cleared for AIS treatment

MDD's Diagnostics Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...